Loading…
Loading…
Rapid7, Inc. (RPD) Presents at Citi's 2026 Global TMT Conference Transcript
Second Rare Pediatric Disease (RPD) Designation for QRX003 FDA Previously Granted RPD Designation for QRX003 in Netherton Syndrome If a New Drug Application (NDA) for QRX003 Is Approved for Peeling Skin Syndrome, Quoin May Receive a Freely Tradable Priority Review Voucher (PRV) Quoin Expects to Initiate Phase 2 Study in 2H 2026; Study Plans to Enroll up to 12 Pediatric and Adult Peeling Skin Patients in the U.S. and Europe There are Currently No Approved Treatments for Peeling Skin Syndrome ASHBURN, Va., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd.
Second Rare Pediatric Disease (RPD) Designation for QRX003 FDA Previously Granted RPD Designation for QRX003 in Netherton Syndrome If a New Drug Application (NDA) for QRX003 Is Approved for Peeling Skin Syndrome, Quoin May Receive a Freely Tradable Priority Review Voucher (PRV) Quoin Expects to Initiate Phase 2 Study in 2H 2026; Study Plans to Enroll up to 12 Pediatric and Adult Peeling Skin Patients in the U.S. and Europe There are Currently No Approved Treatments for Peeling Skin Syndrome ASHBURN, Va., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd.
BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a global leader in AI-powered managed cybersecurity operations, today announced that the company will be attending the following conferences:
On September 02, 2026, Rapid7 Inc (RPD) shares fell 7.8% to $11.07, marking a significant decline in an already challenging year. The stock has fluctuated betwe
Rapid7 remains a 'Buy,' considering the positive read-throughs from its recent quarterly disclosures. RPD's 2Q2026 EPS came in 26% above consensus, as the EBIT margin expanded sequentially by 200bps to 13.7%. The second-quarter beat aligns with my belief that RPD is benefiting from AI-linked demand and cost-cutting under new leadership.
BOSTON, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a global leader in AI-powered managed cybersecurity operations, today released its Quarterly Threat Landscape Report , revealing that rising vulnerability volumes and faster weaponization are breaking traditional patching models. The findings reinforce that security teams must move beyond static severity scores and prioritize the exposures attackers can realistically exploit.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.